Squarepoint
AMGN icon

Squarepoint’s Amgen AMGN Stock Holding History

Squarepoint’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5M Buy
13,800
+1,300
+10% +$445K 0.01% 1604
2026
Q1 		$4.4M Sell
12,500
-3,800
-23% -$1.35M 0.01% 1601
2025
Q4 		$5.34M Sell
16,300
-13,400
-45% -$4.25M 0.01% 1414
2025
Q3 		$8.38M Sell
29,700
-39,200
-57% -$11.4M 0.01% 1168
2025
Q2 		$19.2M Sell
68,900
-5,300
-7% -$1.5M 0.02% 785
2025
Q1 		$23.1M Buy
74,200
+12,900
+21% +$3.81M 0.03% 622
2024
Q4 		$16M Buy
61,300
+38,800
+172% +$11.5M 0.02% 882
2024
Q3 		$7.25M Sell
22,500
-3,000
-12% -$981K 0.01% 1168
2024
Q2 		$7.97M Buy
25,500
+20,600
+420% +$6.05M 0.01% 1067
2024
Q1 		$1.39M Sell
4,900
-31,300
-86% -$9.16M ﹤0.01% 2340
2023
Q4 		$10.4M Sell
36,200
-43,200
-54% -$11.8M 0.02% 918
2023
Q3 		$21.3M Buy
79,400
+69,500
+702% +$17.3M 0.05% 427
2023
Q2 		$2.2M Sell
9,900
-8,700
-47% -$2.02M 0.01% 1601
2023
Q1 		$4.5M Buy
18,600
+8,900
+92% +$2.18M 0.02% 943
2022
Q4 		$2.55M Buy
+9,700
New +$2.6M 0.01% 1224
2022
Q3 		– Sell
-24,500
Closed -$5.96M – 2955
2022
Q2 		$5.96M Sell
24,500
-35,600
-59% -$8.72M 0.03% 596
2022
Q1 		$14.5M Buy
60,100
+30,100
+100% +$6.92M 0.06% 339
2021
Q4 		$6.75M Buy
30,000
+100
+0.3% +$21.1K 0.02% 679
2021
Q3 		$6.36M Buy
29,900
+12,100
+68% +$2.79M 0.02% 668
2021
Q2 		$4.34M Sell
17,800
-51,600
-74% -$12.7M 0.02% 790
2021
Q1 		$17.3M Buy
+69,400
New +$16.6M 0.1% 209
2020
Q4 		– Sell
-800
Closed -$203K – 2878
2020
Q3 		$203K Buy
+800
New +$198K ﹤0.01% 2084
2019
Q4 		– Sell
-1,600
Closed -$310K – 2460
2019
Q3 		$310K Buy
+1,600
New +$307K ﹤0.01% 1886

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Squarepoint's AMGN Position: Q2 2026 in Review

Squarepoint increased its Amgen (AMGN) stake by 13% in Q2 2026, buying an estimated $8.11M and bringing the position to 208,010 shares worth $75.3M. The position accounts for 0.08% of the portfolio, ranked #235.

Squarepoint first reported a position in AMGN in Q4 2014 and has held it in 41 quarters since. The position peaked at $106M in Q2 2023. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Squarepoint held 208,010 shares of Amgen worth $75.3M as of Q2 2026.
  • Squarepoint bought 23,696 Amgen shares in Q2 2026, an estimated $8.11M.
  • Amgen made up 0.08% of Squarepoint's portfolio in Q2 2026, its #235 holding.
  • Squarepoint first reported a position in Amgen in Q4 2014 and has held it in 41 quarters since.
  • Squarepoint's Amgen position peaked at $106M in Q2 2023.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.